Tempus, a pioneer in artificial intelligence and precision medicine, has announced an expansion of its collaboration with pharmaceutical giant AstraZeneca. This enhanced partnership focuses on utilizing Tempus Next, a care pathway intelligence platform, to facilitate the delivery of biomarker testing for patients with non-small cell lung cancer (NSCLC), addressing critical care gaps. Enhancing Precision Medicine […]
Tempus, a pioneering company in the field of artificial intelligence and precision medicine, has announced the integration of its innovative Tempus One technology into the Tempus Lens data analytics platform. This significant development leverages generative AI to provide researchers with powerful tools for analyzing de-identified, multimodal data libraries. The integration aims to facilitate the extraction […]
